Therefore, to assess the role of SLO in vaccine-mediated immunity, we performed skin challenges in which the protective efficacy of J8CombiVax (J8-DT+K4S2-DT/Alum) was assessed against slo-sufficient and -deficient 5448 covR/S mutants using the murine model of skin infection. Here, KCNMA1 is linked to skin infection.